Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus

BACKGROUND: The pharmacokinetic properties of liraglutide, a glucagon-like peptide-1 receptor agonist approved for the treatment of type 2 diabetes mellitus (T2D), have been established in healthy individuals and subjects with T2D. Liraglutide has been under investigation as adjunct treatment to ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Mader, Julia K., Jensen, Lene, Ingwersen, Steen H., Christiansen, Erik, Heller, Simon, Pieber, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069309/
https://www.ncbi.nlm.nih.gov/pubmed/27282158
http://dx.doi.org/10.1007/s40262-016-0413-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069309/
https://www.ncbi.nlm.nih.gov/pubmed/27282158
http://dx.doi.org/10.1007/s40262-016-0413-4

Ejemplares similares